Bezlotoxumab as First Option in Multiple Recurrent Clostridioides Difficile Infection
Clostridioides Difficile
Enrolment: 0 · Results not recorded
Loading the evidence…
Procedure
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Clostridioides Difficile
Enrolment: 0 · Results not recorded
Type 1 Diabetes
Enrolment: 20 · Results not recorded
Obesity
Enrolment: 24 · Results not recorded
Clostridium Difficile · Inflammatory Bowel Disease
Enrolment: 250 · Results not recorded
Infection Resistant to Drugs
Enrolment: 20 · Results not recorded
Steroid-Resistant Nephrotic Syndrome
Enrolment: 120 · Results not recorded
Irritable Bowel Syndrome
Enrolment: 61 · Results not recorded
Irritable Bowel Syndrome
Enrolment: 35 · Results not recorded
Clostridium Difficile Infection
Enrolment: 37 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Experimental acute pancreatitis in mice, compared across antibiotic-treated mice, germ-free mice and mice receiving faecal microbiota transplantation; induction protocol not stated in the abstract
Antibiotic-treated and germ-free mice showed alleviated pancreatic injury after acute pancreatitis induction, whereas subsequent faecal microbiota transplantation exacerbated disease, indicating the microbiota acts as a mediator of severity.
Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.